Advancing biological discoveries into developable therapeutic assets.

​

AnnieGuard's development strategy integrates preclinical efficacy, pharmacokinetic and pharmacodynamic characterization, biomarker development, and intellectual property to build therapeutic discovery programs for pharmaceutical licensing and co-development.

​

Translational Pathway: Following successful functional validation, UPS-01 is designed to advance toward in vivo proof-of-concept, pharmacological characterization, and therapeutic development.